No CrossRef data available.
Article contents
Enterococcal Bacteremia in Cancer Patients
Published online by Cambridge University Press: 02 January 2015
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
![Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0195941700072593/resource/name/firstPage-S0195941700072593a.jpg)
- Type
- Letters to the Editor
- Information
- Copyright
- Copyright © The Society for Healthcare Epidemiology of America 2001
References
1.Goosen, SH. Clinical epidemiology of glycopeptide-resistant enterococci in Europe. In: Brun-Buisson, C, Eliopoulos, G, Leclerq, R, eds. Bacterial Resistance to Glycopeptides. Flammarion, Paris, France: Medicine Sciences; 1998.Google Scholar
2.Edmond, MB, Ober, JF, Weinbaum, DL, Pfaller, MA, Hwang, TG, Sanford, MD. Vancomycin resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126–1133.CrossRefGoogle ScholarPubMed
3.Garbutt, JM, Veertrapragda, M, Littenberg, B, Mundy, L. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin Infect Dis 2000;30:466–472.CrossRefGoogle ScholarPubMed